GAINESVILLE, Fla. — An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as they assess whether a patient would benefit from a daily dose of the drug.
GAINESVILLE, Fla. — More than half of Americans now think marijuana should be legalized, according to survey results the Pew Research Center released in April. But could an inaccurate understanding about modern marijuana and the dangers it poses — particularly to adolescents — be skewing people’s opinions on the subject?
GAINESVILLE, Fla. — University of Florida researchers have developed a “DNA nanotrain” that fast-tracks its payload of cancer-fighting drugs and bioimaging agents to tumor cells deep within the body. The nanotrain’s ability to cost-effectively deliver high doses of drugs to precisely targeted cancers and other medical maladies without leaving behind toxic nano-clutter has been the elusive Holy Grail for scientists studying the teeny-tiny world of DNA nanotechnology.
GAINESVILLE, Fla. — Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients manage treatment-related adverse events.
SVILLE, Fla. — In interviews with nearly 6,000 residents of five U.S. cities, African-Americans were more likely than other racial and ethnic groups to express an interest in participating in medical research, even if studies involved providing blood or genetic samples. The findings appear online ahead of print in the American Journal of Public Health.
GAINESVILLE, Fla. — Black men have the highest incidence of prostate cancer and die more often of the disease than any other group of American men, yet there are significant differences among black men in terms of quality of life and outcomes. Now, University of Florida researchers are exploring these differences among groups of culturally diverse black men with prostate cancer, seeking to understand why.